Click here to get full coverage on Gilead Sciences (GILD) Reports Positive Phase 3 IDEAL Results for Livdelzi in PBC - Yahoo Finance

Gilead Sciences (GILD) Reports Positive Phase 3 IDEAL Results for Livdelzi in PBC  Yahoo Finance

Gilead Sciences (GILD) Reports Positive Phase 3 IDEAL Results for Livdelzi in PBC - Yahoo Finance

Click here to get full coverage on Gilead Sciences, Inc. $GILD Shares Bought by State Street Corp - MarketBeat

Gilead Sciences, Inc. $GILD Shares Bought by State Street Corp  MarketBeat

Gilead Sciences, Inc. $GILD Shares Bought by State Street Corp - MarketBeat

Click here to get full coverage on How Investors Are Reacting To Gilead Sciences (GILD) New HIV Regimen and Liver Disease Milestones - simplywall.st

How Investors Are Reacting To Gilead Sciences (GILD) New HIV Regimen and Liver Disease Milestones  simplywall.st

How Investors Are Reacting To Gilead Sciences (GILD) New HIV Regimen and Liver Disease Milestones - simplywall.st

Click here to get full coverage on Gilead Sciences Inc (GILD) Stock Up 3.6% but GF Value Says Overv - GuruFocus

Gilead Sciences Inc (GILD) Stock Up 3.6% but GF Value Says Overv  GuruFocus

Gilead Sciences Inc (GILD) Stock Up 3.6% but GF Value Says Overv - GuruFocus

Click here to get full coverage on Gilead (GILD) CEO Daniel O'Day exercises RSUs and withholds shares for taxes - Stock Titan

Gilead (GILD) CEO Daniel O'Day exercises RSUs and withholds shares for taxes  Stock Titan

Gilead (GILD) CEO Daniel O'Day exercises RSUs and withholds shares for taxes - Stock Titan

Click here to get full coverage on Is Gilead (GILD) One of the Top Large Cap Value Stocks to Buy Now? - Yahoo Finance

Is Gilead (GILD) One of the Top Large Cap Value Stocks to Buy Now?  Yahoo Finance

Is Gilead (GILD) One of the Top Large Cap Value Stocks to Buy Now? - Yahoo Finance

Click here to get full coverage on Gilead (GILD) Supports Faster South Africa Access to Lenacapavir - Insider Monkey

Gilead (GILD) Supports Faster South Africa Access to Lenacapavir  Insider Monkey

Gilead (GILD) Supports Faster South Africa Access to Lenacapavir - Insider Monkey

Click here to get full coverage on Victory Capital Management Inc. Sells 109,808 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Victory Capital Management Inc. Sells 109,808 Shares of Gilead Sciences, Inc. $GILD  MarketBeat

Victory Capital Management Inc. Sells 109,808 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Click here to get full coverage on Gilead (NASDAQ: GILD) officer reports RSU vesting and tax withholding on Form 4 - Stock Titan

Gilead (NASDAQ: GILD) officer reports RSU vesting and tax withholding on Form 4  Stock Titan

Gilead (NASDAQ: GILD) officer reports RSU vesting and tax withholding on Form 4 - Stock Titan

Click here to get full coverage on Gilead Sciences, Inc. (GILD): a Top Deep Value Stock Making Progress on Pipeline Development - Yahoo Finance

Gilead Sciences, Inc. (GILD): a Top Deep Value Stock Making Progress on Pipeline Development  Yahoo Finance

Gilead Sciences, Inc. (GILD): a Top Deep Value Stock Making Progress on Pipeline Development - Yahoo Finance

Click here to get full coverage on Macquarie Group Ltd. Cuts Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Macquarie Group Ltd. Cuts Stock Holdings in Gilead Sciences, Inc. $GILD  MarketBeat

Macquarie Group Ltd. Cuts Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Click here to get full coverage on Gilead (GILD) CFO exercises 2,796 RSUs and withholds 1,341 shares for taxes - Stock Titan

Gilead (GILD) CFO exercises 2,796 RSUs and withholds 1,341 shares for taxes  Stock Titan

Gilead (GILD) CFO exercises 2,796 RSUs and withholds 1,341 shares for taxes - Stock Titan

Click here to get full coverage on Trillium Asset Management LLC Decreases Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Trillium Asset Management LLC Decreases Stock Position in Gilead Sciences, Inc. $GILD  MarketBeat

Trillium Asset Management LLC Decreases Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Click here to get full coverage on Is Gilead Sciences, Inc. (GILD) A Good Stock To Buy Now? - Yahoo Finance

Is Gilead Sciences, Inc. (GILD) A Good Stock To Buy Now?  Yahoo Finance

Is Gilead Sciences, Inc. (GILD) A Good Stock To Buy Now? - Yahoo Finance

Click here to get full coverage on 2,000 vials of remdesivir rushed to Uganda Ebola outbreak - Stock Titan

2,000 vials of remdesivir rushed to Uganda Ebola outbreak  Stock Titan

2,000 vials of remdesivir rushed to Uganda Ebola outbreak - Stock Titan

Click here to get full coverage on Castleark Management LLC Boosts Stake in Gilead Sciences, Inc. $GILD - MarketBeat

Castleark Management LLC Boosts Stake in Gilead Sciences, Inc. $GILD  MarketBeat

Castleark Management LLC Boosts Stake in Gilead Sciences, Inc. $GILD - MarketBeat

Click here to get full coverage on Gilead (GILD) CMO Dietmar Berger converts RSUs and withholds shares for taxes - Stock Titan

Gilead (GILD) CMO Dietmar Berger converts RSUs and withholds shares for taxes  Stock Titan

Gilead (GILD) CMO Dietmar Berger converts RSUs and withholds shares for taxes - Stock Titan

Click here to get full coverage on Rhenman & Partners Asset Management AB Buys 46,000 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Rhenman & Partners Asset Management AB Buys 46,000 Shares of Gilead Sciences, Inc. $GILD  MarketBeat

Rhenman & Partners Asset Management AB Buys 46,000 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Click here to get full coverage on UniSuper Management Pty Ltd Sells 124,258 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

UniSuper Management Pty Ltd Sells 124,258 Shares of Gilead Sciences, Inc. $GILD  MarketBeat

UniSuper Management Pty Ltd Sells 124,258 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Click here to get full coverage on Gilead Sciences, Inc. $GILD Shares Acquired by Sector Gamma AS - MarketBeat

Gilead Sciences, Inc. $GILD Shares Acquired by Sector Gamma AS  MarketBeat

Gilead Sciences, Inc. $GILD Shares Acquired by Sector Gamma AS - MarketBeat

Click here to get full coverage on Gilead Sciences Inc Stock (GILD) Moved Up by 3.48% on Jun 11: Key Drivers Unveiled - TradingKey

Gilead Sciences Inc Stock (GILD) Moved Up by 3.48% on Jun 11: Key Drivers Unveiled  TradingKey

Gilead Sciences Inc Stock (GILD) Moved Up by 3.48% on Jun 11: Key Drivers Unveiled - TradingKey

Click here to get full coverage on Gilead Sciences Inc (GILD) Shares Fall 3.2% -- What GF Score of 76 Tells Investors - GuruFocus

Gilead Sciences Inc (GILD) Shares Fall 3.2% -- What GF Score of 76 Tells Investors  GuruFocus

Gilead Sciences Inc (GILD) Shares Fall 3.2% -- What GF Score of 76 Tells Investors - GuruFocus

Click here to get full coverage on GILD: Strong pipeline, strategic acquisitions, and long-acting HIV therapies drive long-term growth - TradingView

GILD: Strong pipeline, strategic acquisitions, and long-acting HIV therapies drive long-term growth  TradingView

GILD: Strong pipeline, strategic acquisitions, and long-acting HIV therapies drive long-term growth - TradingView

Click here to get full coverage on Assessing Gilead Sciences (GILD) Valuation As Livdelzi Phase 3 PBC Results Shape Growth Expectations - simplywall.st

Assessing Gilead Sciences (GILD) Valuation As Livdelzi Phase 3 PBC Results Shape Growth Expectations  simplywall.st

Assessing Gilead Sciences (GILD) Valuation As Livdelzi Phase 3 PBC Results Shape Growth Expectations - simplywall.st

Click here to get full coverage on Nuveen LLC Boosts Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Nuveen LLC Boosts Stock Position in Gilead Sciences, Inc. $GILD  MarketBeat

Nuveen LLC Boosts Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Click here to get full coverage on Xponance LLC Has $29.15 Million Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Xponance LLC Has $29.15 Million Stock Position in Gilead Sciences, Inc. $GILD  MarketBeat

Xponance LLC Has $29.15 Million Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Click here to get full coverage on (GILD) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

(GILD) Movement Within Algorithmic Entry Frameworks  Stock Traders Daily

(GILD) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Click here to get full coverage on Gilead Sciences, Inc. $GILD Shares Acquired by LPL Financial LLC - MarketBeat

Gilead Sciences, Inc. $GILD Shares Acquired by LPL Financial LLC  MarketBeat

Gilead Sciences, Inc. $GILD Shares Acquired by LPL Financial LLC - MarketBeat

Click here to get full coverage on GILD: Strong pipeline, strategic acquisitions, and disciplined growth drive long-term outlook - TradingView

GILD: Strong pipeline, strategic acquisitions, and disciplined growth drive long-term outlook  TradingView

GILD: Strong pipeline, strategic acquisitions, and disciplined growth drive long-term outlook - TradingView

Click here to get full coverage on Gilead Sciences Inc Stock (GILD) Closed Down by 3.12% on Jun 10: What Investors Need To Know - TradingKey

Gilead Sciences Inc Stock (GILD) Closed Down by 3.12% on Jun 10: What Investors Need To Know  TradingKey

Gilead Sciences Inc Stock (GILD) Closed Down by 3.12% on Jun 10: What Investors Need To Know - TradingKey

Click here to get full coverage on Gilead Sciences Target of Unusually Large Options Trading (NASDAQ:GILD) - MarketBeat

Gilead Sciences Target of Unusually Large Options Trading (NASDAQ:GILD)  MarketBeat

Gilead Sciences Target of Unusually Large Options Trading (NASDAQ:GILD) - MarketBeat

Click here to get full coverage on Gilead Sciences, Inc. $GILD Shares Sold by BLI Banque de Luxembourg Investments - MarketBeat

Gilead Sciences, Inc. $GILD Shares Sold by BLI Banque de Luxembourg Investments  MarketBeat

Gilead Sciences, Inc. $GILD Shares Sold by BLI Banque de Luxembourg Investments - MarketBeat

Click here to get full coverage on GILD Donates Antiviral Therapy to Support Ebola Response in Ugan - GuruFocus

GILD Donates Antiviral Therapy to Support Ebola Response in Ugan  GuruFocus

GILD Donates Antiviral Therapy to Support Ebola Response in Ugan - GuruFocus

Click here to get full coverage on Gilead Balances Trodelvy Setback With Once Weekly HIV Progress - simplywall.st

Gilead Balances Trodelvy Setback With Once Weekly HIV Progress  simplywall.st

Gilead Balances Trodelvy Setback With Once Weekly HIV Progress - simplywall.st

Click here to get full coverage on Gilead Sciences (GILD), Lakefront Biotherapeutics Acquire Ouro Medicines to Advance Autoimmune Pipeline - Yahoo Finance

Gilead Sciences (GILD), Lakefront Biotherapeutics Acquire Ouro Medicines to Advance Autoimmune Pipeline  Yahoo Finance

Gilead Sciences (GILD), Lakefront Biotherapeutics Acquire Ouro Medicines to Advance Autoimmune Pipeline - Yahoo Finance

Click here to get full coverage on Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Weakness - Yahoo Finance

Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Weakness  Yahoo Finance

Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Weakness - Yahoo Finance

Click here to get full coverage on Long term debt to total assets ratio of Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh – BCBA:GILD.CI - TradingView

Long term debt to total assets ratio of Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh – BCBA:GILD.CI  TradingView

Long term debt to total assets ratio of Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh – BCBA:GILD.CI - TradingView

Click here to get full coverage on Citi Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $165 - Moomoo

Citi Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $165  Moomoo

Citi Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $165 - Moomoo

Click here to get full coverage on Gilead Sciences (GILD) Announces New Results From a Post Hoc Analysis - Yahoo Finance

Gilead Sciences (GILD) Announces New Results From a Post Hoc Analysis  Yahoo Finance

Gilead Sciences (GILD) Announces New Results From a Post Hoc Analysis - Yahoo Finance

Click here to get full coverage on Maxim Upgrades Gilead Sciences (GILD) to ‘Buy’ - Yahoo Finance

Maxim Upgrades Gilead Sciences (GILD) to ‘Buy’  Yahoo Finance

Maxim Upgrades Gilead Sciences (GILD) to ‘Buy’ - Yahoo Finance

Click here to get full coverage on Franklin Resources Inc. Sells 169,087 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Franklin Resources Inc. Sells 169,087 Shares of Gilead Sciences, Inc. $GILD  MarketBeat

Franklin Resources Inc. Sells 169,087 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Click here to get full coverage on Is It Time To Reassess Gilead Sciences (GILD) After Strong Multi Year Share Price Gains - Yahoo Finance

Is It Time To Reassess Gilead Sciences (GILD) After Strong Multi Year Share Price Gains  Yahoo Finance

Is It Time To Reassess Gilead Sciences (GILD) After Strong Multi Year Share Price Gains - Yahoo Finance

Click here to get full coverage on Gilead Sciences, Inc. (GILD) Gains Attention as Livdelzi Demonstrates Long-Term Efficacy and Safety - Yahoo Finance

Gilead Sciences, Inc. (GILD) Gains Attention as Livdelzi Demonstrates Long-Term Efficacy and Safety  Yahoo Finance

Gilead Sciences, Inc. (GILD) Gains Attention as Livdelzi Demonstrates Long-Term Efficacy and Safety - Yahoo Finance

Click here to get full coverage on A Quick Look at Today's Ratings for Gilead Sciences(GILD.US), With a Forecast Between $155 to $165 - Moomoo

A Quick Look at Today's Ratings for Gilead Sciences(GILD.US), With a Forecast Between $155 to $165  Moomoo

A Quick Look at Today's Ratings for Gilead Sciences(GILD.US), With a Forecast Between $155 to $165 - Moomoo

Click here to get full coverage on Vaughan David Investments LLC IL Invests $33.80 Million in Gilead Sciences, Inc. $GILD - MarketBeat

Vaughan David Investments LLC IL Invests $33.80 Million in Gilead Sciences, Inc. $GILD  MarketBeat

Vaughan David Investments LLC IL Invests $33.80 Million in Gilead Sciences, Inc. $GILD - MarketBeat

Click here to get full coverage on How Investors Are Reacting To Gilead Sciences (GILD) Expanding Liver And Oncology Drug Footprint - Yahoo Finance

How Investors Are Reacting To Gilead Sciences (GILD) Expanding Liver And Oncology Drug Footprint  Yahoo Finance

How Investors Are Reacting To Gilead Sciences (GILD) Expanding Liver And Oncology Drug Footprint - Yahoo Finance

Click here to get full coverage on Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance Singapore

Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know  Yahoo Finance Singapore

Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance Singapore

Click here to get full coverage on Merck (MRK) and Gilead Sciences (GILD) Achieve Key Trial Milesto - GuruFocus

Merck (MRK) and Gilead Sciences (GILD) Achieve Key Trial Milesto  GuruFocus

Merck (MRK) and Gilead Sciences (GILD) Achieve Key Trial Milesto - GuruFocus

Click here to get full coverage on Gilead (GILD) to Showcase New Cancer Therapy Data - Yahoo Finance

Gilead (GILD) to Showcase New Cancer Therapy Data  Yahoo Finance

Gilead (GILD) to Showcase New Cancer Therapy Data - Yahoo Finance

Click here to get full coverage on Gilead Sciences, Inc. $GILD Shares Bought by Erste Asset Management GmbH - MarketBeat

Gilead Sciences, Inc. $GILD Shares Bought by Erste Asset Management GmbH  MarketBeat

Gilead Sciences, Inc. $GILD Shares Bought by Erste Asset Management GmbH - MarketBeat

Click here to get full coverage on Calamos Growth & Income Portfolio's Gilead Sciences Inc(GILD) Holding History - GuruFocus

Calamos Growth & Income Portfolio's Gilead Sciences Inc(GILD) Holding History  GuruFocus

Calamos Growth & Income Portfolio's Gilead Sciences Inc(GILD) Holding History - GuruFocus

Click here to get full coverage on Gilead (GILD) Wins FDA Approval for First HDV Treatment Hepcludex - Yahoo Finance

Gilead (GILD) Wins FDA Approval for First HDV Treatment Hepcludex  Yahoo Finance

Gilead (GILD) Wins FDA Approval for First HDV Treatment Hepcludex - Yahoo Finance

Click here to get full coverage on Motley Fool Asset Management LLC Buys 29,394 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Motley Fool Asset Management LLC Buys 29,394 Shares of Gilead Sciences, Inc. $GILD  MarketBeat

Motley Fool Asset Management LLC Buys 29,394 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Click here to get full coverage on Gilead Sciences Inc. (NASDAQ: GILD) Holds Steady as HIV and Oncology Portfolio Drives Income - foreignpolicyjournal.com

Gilead Sciences Inc. (NASDAQ: GILD) Holds Steady as HIV and Oncology Portfolio Drives Income  foreignpolicyjournal.com

Gilead Sciences Inc. (NASDAQ: GILD) Holds Steady as HIV and Oncology Portfolio Drives Income - foreignpolicyjournal.com

Click here to get full coverage on Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It  Yahoo Finance

Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Click here to get full coverage on Gilead, Merck Report Positive Phase III HIV Study Data, End NSCLC Study - TradingView

Gilead, Merck Report Positive Phase III HIV Study Data, End NSCLC Study  TradingView

Gilead, Merck Report Positive Phase III HIV Study Data, End NSCLC Study - TradingView

Click here to get full coverage on Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology Portfolio - Yahoo Finance

Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology Portfolio  Yahoo Finance

Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology Portfolio - Yahoo Finance

Click here to get full coverage on Morgan Stanley Reassesses Gilead Sciences (GILD) Outlook Following Quarterly Report - Yahoo Finance

Morgan Stanley Reassesses Gilead Sciences (GILD) Outlook Following Quarterly Report  Yahoo Finance

Morgan Stanley Reassesses Gilead Sciences (GILD) Outlook Following Quarterly Report - Yahoo Finance

Click here to get full coverage on Gilead Sciences (GILD) Reiterated at Overweight by Cantor Fitzgerald - StreetInsider

Gilead Sciences (GILD) Reiterated at Overweight by Cantor Fitzgerald  StreetInsider

Gilead Sciences (GILD) Reiterated at Overweight by Cantor Fitzgerald - StreetInsider

Click here to get full coverage on GILD Stock Jumps After Winning Accelerated FDA Approval For HDV Treatment - Stocktwits

GILD Stock Jumps After Winning Accelerated FDA Approval For HDV Treatment  Stocktwits

GILD Stock Jumps After Winning Accelerated FDA Approval For HDV Treatment - Stocktwits

Click here to get full coverage on Gilead Sciences (GILD) Has an HIV-and-Oncology Bridge That Makes the Base Business Harder to Ignore - AlphaStreet

Gilead Sciences (GILD) Has an HIV-and-Oncology Bridge That Makes the Base Business Harder to Ignore  AlphaStreet

Gilead Sciences (GILD) Has an HIV-and-Oncology Bridge That Makes the Base Business Harder to Ignore - AlphaStreet

Click here to get full coverage on Capital World Investors Has $5.26 Billion Stake in Gilead Sciences, Inc. $GILD - MarketBeat

Capital World Investors Has $5.26 Billion Stake in Gilead Sciences, Inc. $GILD  MarketBeat

Capital World Investors Has $5.26 Billion Stake in Gilead Sciences, Inc. $GILD - MarketBeat

Click here to get full coverage on Gilead Sciences (NASDAQ:GILD) Screens as a Top Dividend Stock with Strong Profitability and Health - ChartMill

Gilead Sciences (NASDAQ:GILD) Screens as a Top Dividend Stock with Strong Profitability and Health  ChartMill

Gilead Sciences (NASDAQ:GILD) Screens as a Top Dividend Stock with Strong Profitability and Health - ChartMill

Click here to get full coverage on South Africa rolls out long-acting HIV prevention from Gilead - Stock Titan

South Africa rolls out long-acting HIV prevention from Gilead  Stock Titan

South Africa rolls out long-acting HIV prevention from Gilead - Stock Titan

Click here to get full coverage on How Liver and Oncology Wins Will Impact Gilead Sciences (GILD) Investors - simplywall.st

How Liver and Oncology Wins Will Impact Gilead Sciences (GILD) Investors  simplywall.st

How Liver and Oncology Wins Will Impact Gilead Sciences (GILD) Investors - simplywall.st

Click here to get full coverage on Gilead Sciences (NASDAQ: GILD) Form 144 lists 35,000 shares for resale - Stock Titan

Gilead Sciences (NASDAQ: GILD) Form 144 lists 35,000 shares for resale  Stock Titan

Gilead Sciences (NASDAQ: GILD) Form 144 lists 35,000 shares for resale - Stock Titan

Click here to get full coverage on RBC Capital: 'Where Does Gilead Sciences (GILD) Stand With In Vivo CAR-T?' - StreetInsider

RBC Capital: 'Where Does Gilead Sciences (GILD) Stand With In Vivo CAR-T?'  StreetInsider

GILD

Price Chart

Key Statistics

Technicals

About GILD

Latest News

Gilead Sciences (GILD) Reports Positive Phase 3 IDEAL Results for Livdelzi in PBC - Yahoo Finance

Gilead Sciences, Inc. $GILD Shares Bought by State Street Corp - MarketBeat

How Investors Are Reacting To Gilead Sciences (GILD) New HIV Regimen and Liver Disease Milestones - simplywall.st

Advanced Charts

Top Gainers

Top Losers